|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 45, 71-80, January 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology
Division of Nutritional Sciences, Savage Hall, Cornell University, Ithaca, NY 14853
6 To whom correspondence should be addressed. e-mail: jtb4{at}cornell.edu
Infant formulas supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA) are now available in the United States; however, little is known about the factors that affect biosynthesis. Baboon neonates were assigned to one of four treatments: term, breast-fed; term, formula-fed; preterm (155 of 182 days gestation), formula-fed; and preterm, formula+DHA/ARA-fed. Standard formula had no DHA/ARA; supplemented formula had 0.61%wt DHA (0.3% of calories) and 1.21%wt ARA (0.6% of calories), and baboon breast milk contained 0.68 ± 0.22%wt DHA and 0.62 ± 0.12%wt ARA. At 14 days adjusted age, neonates received a combined oral dose of [U-13C]
-linolenic acid (LNA*) and [U-13C]linoleic acid (LA*), and tissues were analyzed 14 days after dose. Brain accretion of linolenic acid-derived DHA was
3-fold greater for the formula groups than for the breast-fed group, and dietary DHA partially attenuated excess DHA synthesis among preterms. A similar, significant pattern was found in other organs. Brain linoleic acid-derived ARA accretion was significantly greater in the unsupplemented term group but not in the preterm groups compared with the breast-fed group.
These data show that formula potentiates the biosynthesis/accretion of DHA/ARA in term and preterm neonates compared with breast-fed neonates and that the inclusion of DHA/ARA in preterm formula partially restores DHA/ARA biosynthesis to lower, breast-fed levels. Current formula DHA concentrations are inadequate to normalize long-chain polyunsaturated fatty acids synthesis to that of breast-fed levels.
Abbreviations: ARA or 20:4n-6, arachidonic acid; CNS, central nervous system; DHA or 22:6n-3, docosahexaenoic acid; FA, fatty acid; FAME, fatty acid methyl ester; LA, linoleic acid; LA*, [U-13C]linoleic acid; LCP, long-chain polyunsaturated fatty acid; LNA,
-linolenic acid; LNA*, [U-13C]
-linolenic acid; RBC, red blood cell; RPE, retinal pigment epithelium
Supplementary key words stable isotope tracers isotope ratio mass spectrometry n-3 long-chain polyunsaturated fatty acids n-6 long-chain polyunsaturated fatty acids
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. H. Lin and N. Salem Jr. Whole body distribution of deuterated linoleic and {alpha}-linolenic acids and their metabolites in the rat J. Lipid Res., December 1, 2007; 48(12): 2709 - 2724. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Igarashi, K. Ma, L. Chang, J. M. Bell, S. I. Rapoport, and J. C. DeMar Jr. Low liver conversion rate of {alpha}-linolenic to docosahexaenoic acid in awake rats on a high-docosahexaenoate-containing diet J. Lipid Res., August 1, 2006; 47(8): 1812 - 1822. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |